New HCPC Modifier—ZC
The following information appeared on CMS.gov
CMS updated the 2016 Physician Fee Schedule Final rule to make the payment for biosimilar biological drug product based on
the average sales price for the NDCs assigned to the biosimilar biological drug products included within the same billing and
payment code. In order to track claims payment and understand how the each separate biological drug is used, each product has a modifier used to distinguish it from other manufacturers.
To read the full article, visit CMS.gov